FFL Partners Invests in Johnson County Clin-Trials, Revolutionizing Clinical Research

SAN FRANCISCO -- FFL Partners, a private equity firm specializing in healthcare and tech-enabled services, has completed a growth investment in Johnson County Clin-Trials (JCCT). JCCT is a leading platform for clinical research sites, serving pharmaceutical and biotechnology companies and contract research organizations (CROs). This strategic partnership aims to propel JCCT into a position of leadership within the clinical trial sector and drive their expansion and growth trajectory.

Headquartered in Lenexa, Kansas, JCCT specializes in Phase I - IV clinical trials, involving both healthy volunteers and special populations. With a proven track record of successfully conducting over 300 clinical trials and engaging more than 15,000 study participants, JCCT has excelled in patient engagement and data integrity, enabling sponsors to conduct high-quality and cost-effective trials.

FFL Partners recognizes JCCT's prowess in executing clinical trials and their ability to consistently exceed patient enrollment targets. By collaborating with the founders, FFL aims to leverage their collective experience and resources to further enhance JCCT's services and solidify their position within the fragmented clinical research site sector.

Nathan Arthur, Co-CEO and Co-Founder of JCCT, states, "Our collaboration with FFL infuses substantial resources that will power the expansion of our footprint, and we're confident this investment will invigorate our patient recruitment endeavors and expedite our growth trajectory."

Mazen Zari, Co-CEO and Co-Founder of JCCT, adds, "With FFL's support, we are enthusiastic about our ability to pursue strategic M&A transactions within the fragmented clinical research site sector. We are eagerly looking forward to joining forces with other high-caliber research sites in the future."

The partnership with FFL Partners will also bolster JCCT's leadership team, as Jeanne Hecht, CEO & Founder of JTH Consulting, assumes a role on the JCCT Board of Directors.

Chris Harris, Managing Partner at FFL Partners, expresses excitement about the partnership, stating, "FFL's established track record of collaborating with founders to elevate and expand their enterprises positions us perfectly to contribute to JCCT's accelerated growth trajectory."

FFL Partners, based in San Francisco, is a leading middle-market private equity firm with a specialization in healthcare and tech-enabled services. Their focus on targeted areas within these sectors, along with their proprietary sourcing and value creation strategy, has enabled FFL to partner with exceptional management teams and drive growth in their portfolio businesses.

Johnson County Clin-Trials (JCCT) has been providing clinical research services to pharmaceutical and biotechnology companies and CROs since 2005. With expertise in Phase I - IV outpatient/inpatient clinical trials, including special populations studies and First-In-Man studies, JCCT has played a crucial role in the development and approval of 23 new or improved drugs/vaccines brought to market. Their accumulated experience and knowledge have paved the way for successful study conduct, assuring sponsors of their dedication to quality research.

Through this partnership, FFL Partners and JCCT aim to shape the future of clinical research by driving innovation, expanding their services, and providing sponsors with top-quality data and exceptional care to study participants. The combined expertise and resources of FFL Partners and JCCT will revolutionize the landscape of clinical trials and pave the way for improved healthcare outcomes.

For more information about FFL Partners, please visit [www.fflpartners.com](https://www.fflpartners.com/).

To learn more about Johnson County Clin-Trials (JCCT) and their clinical research services, please visit [www.jcct.com](http://www.jcct.com/).